Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
* The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
CUSIP No. 124155102
|
|
1.
|
Names of Reporting Persons.
|
|
I.R.S. Identification Nos. of above persons (entities only).
|
|
|
Fosun Industrial Co., Limited
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a) ¨
|
|
|
(b) ¨
|
|
|
|
|
3.
|
SEC Use Only
|
|
|
|
4.
|
Citizenship or Place of Organization
|
|
|
Hong Kong
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
10,716,630
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
10,716,630
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
10,716,630 (1)
|
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
|
|
|
¨
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
|
|
6.5% (2)
|
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
CO
|
|
|
(1)
Consists of 10,716,630 shares of Class A common stock of Butterfly Network, Inc. (f/k/a
Longview Acquisition Corp.) (the “Issuer”) held by Fosun Industrial Co., Limited.
(2) Calculated based on 164,862,472 shares of Class A common
stock of the Issuer outstanding as of February 12, 2021 as reported in the Issuer’s Form 8-K filed with the Securities Exchange
Commission on February 16, 2021.
CUSIP No. 124155102
|
1.
|
Names of Reporting Persons.
|
|
I.R.S. Identification Nos. of above persons (entities only).
|
|
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a) ¨
|
|
|
(b) ¨
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Citizenship or Place of Organization
|
|
|
China
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
10,716,630
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
10,716,630
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
10,716,630 (3)
|
|
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
|
|
|
¨
|
|
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
|
|
|
6.5% (4)
|
|
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
CO
|
|
|
(3)
Consists of 10,716,630 shares of Class A common stock of Butterfly Network, Inc. (f/k/a Longview Acquisition Corp.) (the “Issuer”)
held by Fosun Industrial Co., Limited.
(4)
Calculated based on 164,862,472 shares of Class A common stock of the Issuer outstanding as of February 12, 2021 as reported in
the Issuer’s Form 8-K filed with the Securities Exchange Commission on February 16, 2021.
Item 1.
(a) Name
of Issuer:
Butterfly Network, Inc.
(b) Address
of Issuer's Principal Executive Offices:
530 Old Whitfield Street, Guilford, Connecticut 06437
Item 2.
(a)-(c):
This Statement is being filed on
behalf of (i) Fosun Industrial Co., Limited, (“Fosun Industrial”) and (ii) Shanghai Fosun Pharmaceutical (Group) Co.,
Ltd. (“Fosun Pharma”). Fosun Industrial and Fosun Pharma are each referred to herein as a “Reporting Person”
and are collectively referred to herein as the “Reporting Persons”. The agreement between the Reporting Persons relating
to the joint filing of this Statement is attached hereto as Exhibit 99.1.
The address of the principal business
office for Fosun Industrial is Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong. The address of the principal
business office for Fosun Pharma is No. 1289 Yishan Road (Building A, Fosun Technology Park), Shanghai 200233, People’s Republic
of China.
Fosun Industrial is a company incorporated
under the laws of Hong Kong. Fosun Industrial is principally engaged in foreign investment, sale and consultancy service of Chinese
and western medicine, diagnostic reagent, medical device products and relevant import and export business. Fosun Industrial is
a wholly-owned subsidiary of Fosun Pharma.
Fosun Pharma is a corporation organized
under the laws of People’s Republic of China and listed on the Shanghai Stock Exchange and the Stock Exchange of Hong Kong
Limited. Fosun Pharma’s business covers all key sectors of healthcare industry chain, including pharmaceutical manufacturing
and R&D, medical devices and medical diagnosis, healthcare services, as well as pharmaceutical distribution and retail. Fosun
Pharma is a subsidiary of, and is beneficially held approximately39.39% by, Shanghai Fosun High Technology (Group) Co. Ltd. (“Fosun
High Technology”).
Fosun High Technology is a wholly-owned
subsidiary of Fosun International Limited (“Fosun International”) and performs its parent company’s business
operation in Mainland China. Fosun International is a technology-driven consumer group which operates three business lines in Health,
Happiness and Wealth, and is principally engaged in creating world-class products and services for families around the world. Fosun
International is a Hong Kong company, the ordinary shares of which are listed on the main board of The Stock Exchange of Hong Kong
Limited. Fosun International is a subsidiary of, and is beneficially held approximately 71.92% by Fosun Holdings Limited (“Fosun
Holdings”). Fosun Holdings is an investment holding company. Fosun Holdings is a wholly-owned subsidiary of Fosun International
Holdings Ltd. (“Fosun International Holdings”). Fosun International Holdings is an investment holding company. Fosun
International Holdings is beneficially held approximately 85.29% by Guo Guangchang and 14.71% by Wang Qunbin. Guo Guangchang controls
Fosun International Holdings and could therefore be deemed the beneficial owner of the securities held by Fosun Industrial.
(d) Title
of Class of Securities:
Class A common stock, par value
of $0.0001 per share
(e) CUSIP
Number:
124155102
|
Item 3.
|
If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the
person filing is a:
|
Not applicable
(a) Amount
beneficially owned:
The information required by Items
4(a) is set forth in Row 9 of the cover page for each Reporting Person and is incorporated herein by reference.
(b) Percent
of class:
The information required by Items
4(a) is set forth in Row 11 of the cover page for each Reporting Person and is incorporated herein by reference.
(c) Number
of shares as to which the person has:
The information required by Items
4(c) is set forth in Rows 5-8 of the cover page for each Reporting Person and is incorporated herein by reference.
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
Not applicable
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Not applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported
on By the Parent Holding Company or Control Person
|
Not applicable
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not applicable
|
Item 9.
|
Notice of Dissolution of Group
|
Not applicable
By signing below the reporting persons certify that, to the
best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 22, 2021
|
Fosun Industrial Co., Limited
|
|
|
|
By:
|
/s/ Xiaohui Guan
|
|
Name: Xiaohui Guan
|
|
Title: Director
|
|
|
|
Shanghai Fosun Pharmaceutical
(Group) Co., Ltd.
|
|
|
|
By:
|
/s/ Yifang Wu
|
|
Name: Yifang Wu
|
|
Title: Chairman and Chief Executive
Officer
|
Exhibit Index